Brokerages Set Masimo Corporation (NASDAQ:MASI) PT at $180.40

Masimo Corporation (NASDAQ:MASI) has been given a consensus rating of “Hold” by the nine brokerages that are presently covering the stock, Marketbeat reports. Nine analysts have rated the stock with a hold rating. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $180.40.

A number of brokerages recently issued reports on MASI. Stifel Nicolaus set a $180.00 target price on Masimo in a research report on Tuesday, February 17th. Weiss Ratings raised Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Wells Fargo & Company raised Masimo to a “hold” rating in a research report on Wednesday, March 18th. BTIG Research lowered Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Finally, Piper Sandler downgraded Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target for the company. in a research note on Tuesday, February 17th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Global Retirement Partners LLC bought a new position in shares of Masimo during the 4th quarter worth approximately $27,000. Aster Capital Management DIFC Ltd bought a new position in shares of Masimo during the 4th quarter worth approximately $28,000. Los Angeles Capital Management LLC bought a new position in shares of Masimo during the 4th quarter worth approximately $31,000. Western Wealth Management LLC bought a new position in shares of Masimo during the 1st quarter worth approximately $44,000. Finally, Rothschild Investment LLC boosted its stake in shares of Masimo by 12,950.0% during the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 259 shares during the period. 85.96% of the stock is currently owned by institutional investors.

Masimo Stock Performance

NASDAQ MASI opened at $179.95 on Wednesday. The firm has a market cap of $9.42 billion, a P/E ratio of -17.07, a P/E/G ratio of 1.82 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.45. The stock’s 50-day moving average is $178.70 and its 200-day moving average is $160.66. Masimo has a one year low of $125.94 and a one year high of $179.99.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.